Why these 4 ASX shares are sinking lower today

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is one of four sinking lower on the ASX on Wednesday. Here's what you need to know…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to finish the day in the red. At the time of writing the benchmark index is down 0.1% to 5,721.4 points.

Four shares falling more than most today are listed below. Here's why they are sinking lower:

The Ausdrill Limited (ASX: ASL) share price is down almost 7% to $1.32 despite there being no news out of the diversified mining services company. At one stage today Ausdrill's shares fell to a 52-week low of $1.26. The company's shares have come under significant selling pressure since it announced the acquisition of Barminco and the loss of a mining contract at the Edikan gold mine in August.

The Accent Group Ltd (ASX: AX1) share price has dropped 4.5% to $1.28. I suspect that a spot of profit taking is happening today after Accent Group's shares rocketed higher last week following its positive AGM update. One broker that thinks this is a buying opportunity is Morgans. Earlier this week it upgraded the footwear retailer's shares to an add rating with a $1.46 price target.

The Admedus Ltd (ASX: AHZ) share price has returned from its suspension and crashed 55% lower to 6 cents. Admedus' shares have been suspended since the start of August whilst it went through a recapitalisation plan. This morning it launched a partially underwritten entitlement offer to raise up to $20.2 million before costs. The capital raised from this rights issue will provide funding for Admedus to consolidate and further develop its ADAPT portfolio and position itself for the development of new products in 2019.

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has dropped 7% lower to $1.18. This morning the biopharmaceutical company was the subject of another broker note out of Morgans. According to the note, the broker has initiated coverage on Paradigm with a reduce (sell) rating and 89 cents price target. The broker believes that high levels of trial success relating to the repurposing of pentosan polysulfate sodium have been priced in already.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Beach Energy, Myer, Pexa, and Pinnacle shares are falling today

These shares are under pressure on Thursday. What's going?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling today

These shares are having a tough time on hump day. What's going on?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Fisher & Paykel Healthcare, Magellan, Resolute Mining, and Westgold shares are sinking today

These shares are starting the week deep in the red. But why?

Read more »

plummeting gold share price
Gold

Guess which ASX 200 gold stock just plunged 12% on FY 2025 production woes

The ASX 200 gold stock is taking a sharp fall on Monday. Let’s find out why.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

These were the worst performing ASX 200 shares in January 2025

These shares had a month to forget. Why were investors selling them? Let's find out.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Magellan, Medadvisor, Origin Energy, and Pointsbet shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today
Share Fallers

Why Appen, Credit Corp, Mineral Resources, and Zip shares are sinking today

These shares are missing out on the good times on Thursday and dropping into the red.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Accent, Aroa, Playside, and Premier Investments shares are tumbling today

These shares are having a tough time on hump day. But why?

Read more »